Bayer AG Sponsored ADR (BAYRY)
Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug
Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.
Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress
Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next-gen genetic medicines.
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bayer sues COVID vaccine makers over mRNA technology
Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology in manufacturing their vaccines, a Bayer spokesperson confirmed.
BAYRY's 2025 Revival: Will the Momentum Continue in 2026?
BAYRY shares have risen 121.6% in a year as new FDA approvals, pipeline wins and litigation updates fuel a sharp turnaround.
Bayer: Is This The Turning Point Investors Have Been Waiting For?
Bayer Aktiengesellschaft remains deeply undervalued despite ongoing operational and litigation headwinds, supporting a bullish stance. Q3/25 results were weak, but technicals and intrinsic value calculations indicate potential upside, especially if glyphosate litigation abates. Trump administration support for Supreme Court review of glyphosate cases could materially reduce litigation provisions and unlock value.
Bayer Stock Up as Government Backs Supreme Court Review in Roundup Case
Bayer shares jump after the U.S. Solicitor General backs a Supreme Court review of its Roundup case, adding momentum to its strong 2025 run.
Why Bayer Aktiengesellschaft (BAYRY) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why the Maker of Roundup Weed Killer's Stock Is Surging Today
Shares of pharmaceutical conglomerate Bayer (BAYRY) are surging 12% on their home exchange in Germany after the U.S. Solicitor General supported its efforts to have the Supreme Court review prior rulings on whether Roundup weed killer, produced by Bayer-owned Monsanto, needs a cancer risk warning label.
Bayer stock has its best day in 17 years after support from Trump's solicitor general
Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company's bid to get the Supreme Court to curtail litigation alleging its Roundup pesticide causes cancer.
Trump administration backs Bayer's bid to curb Roundup lawsuits
President Donald Trump's administration urged the U.S. Supreme Court on Monday to take up Bayer's bid to curtail thousands of lawsuits claiming its Roundup weedkiller causes cancer, backing the company's argument that federal law bars the claims.
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
